F-1/A: Empro Group Inc. Files for IPO, Aiming to List on Nasdaq

Empro Group Inc., a Cayman Islands-based company with Malaysian operations, has filed an amendment to its registration statement for an initial public offering of 1,250,000 ordinary shares, seeking Nasdaq listing under the symbol EMPG.

Summary

• Empro Group Inc., a Cayman Islands company, is planning an initial public offering (IPO) of 1,250,000 ordinary shares.
• The company expects the IPO price to be between $4.00 and $4.50 per share.
• Empro Group has applied to list its Ordinary Shares on the Nasdaq Capital Market under the symbol EMPG.
• The company's founder, Yeoh Chee Wei, is expected to own approximately 64.7% of the outstanding Ordinary Shares after the offering.
• Empro Group operates through its Malaysian subsidiary, EMP Solution Sdn. Bhd., focusing on healthcare and beauty products.
• For the fiscal year ended December 31, 2024, Empro Group had a net profit of approximately $0.75 million, and for the fiscal year ended December 31, 2023, it experienced a net loss of approximately $0.32 million.
• The company intends to use the proceeds from the offering for working capital, market penetration and development, operating expenses and transaction expenses.

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While the company reports a net profit for the most recent fiscal year and outlines growth strategies, it also acknowledges risks and challenges, including a competitive industry and reliance on third-party suppliers. The IPO itself is a positive step, but the company's future success is not guaranteed.

Positives

• The company has a rich brand history spanning over 19 years.
• The company has a track record of consistently delivering safe, efficacious and innovative beauty and healthcare products.
• The company has developed strong relationships with partners, regulators and government agencies.
• The company boasts a robust and experienced management team.
• The company's revenue diversification following the introduction of new products in the beauty segment enhances its financial resilience.

Negatives

• The company operates in a dynamic healthcare and beauty industry and has a limited operating history.
• The healthcare industry and the beauty industry are highly competitive.
• The company's total revenue, and the revenue generated by its healthcare business segment, decreased considerably during the 2023 fiscal year due to a marked reduction in COVID-19 cases.
• The company relies on a limited number of ODM/OEM and packaging supply partners to produce its products.
• The company may not be able to successfully implement its growth strategy.

Risks

• The company's historical results may not be indicative of future performance.
• The company's success depends on the continued popularity of its products and its ability to respond to changes in industry trends.
• New product introductions may not be as successful as anticipated.
• The company relies on third-party e-commerce platforms to sell its products online.
• The sale of counterfeit products may affect the company's reputation and profitability.
• The company's operating results could be materially harmed if it is unable to accurately forecast consumer demand for its products or adequately manage its inventory.
• The company's business and prospects depend on its ability to build its brands and reputation, which could be harmed by negative publicity.
• The market for beauty products in Malaysia and Southeast Asia may not grow as quickly as expected.
• Fluctuations in exchange rates in the MYR could adversely affect the company's business and the value of its securities.
• The company is controlled by a single shareholder, whose interests in the business may be different than yours.

Future Outlook

The company plans to expand its product offerings, enter new markets within ASEAN and Europe, and invest in new technologies to strengthen brand loyalty and develop its business.

Management Comments

• Under the leadership of our founder, Yeoh Chee Wei, our company has steadily and successfully transcended its humble origins in the beauty industry during an operating history that spans nearly two decades.
• We believe that this multifaceted strategic synergy will remain pivotal in securing sustained success and a prominent industry position as we navigate into the future.

Industry Context

The beauty market is experiencing significant growth globally and in the Asia-Pacific region, while the Personal Protective Equipment (PPE) market is also expanding, presenting diversified revenue streams for Empro Group.

Comparison to Industry Standards

• The beauty industry is highly competitive, with rivalry from national and international entities, including large multinational consumer product companies such as LOreal Group (Shu Uemura, Kiehls) and The Este Lauder Companies (Bobbi Brown).
• The company's SpaceLift skincare product competes with brands like Clarins, SK-II, Kiehls, Hada Labo, and Eucerin.
• The company's medical face mask products compete with Malaysian brands Medicos and Neutrovis.

Related Party Transactions

• The company has significant related party transactions with Jingga Anggun Sdn Bhd and Mosfac Sdn Bhd, including supply agreements and outstanding receivables/payables.
• Yeoh Chee Wei, the CEO and director, has relationships with these related parties, including being a shareholder and director of Mosfac Sdn Bhd and the son of the director of Jingga Anggun Sdn Bhd.

Stakeholder Impact

• The IPO will provide capital for the company's growth and expansion, potentially benefiting shareholders.
• The company's success depends on its ability to meet consumer demand and maintain its reputation, impacting customers.
• The company's reliance on third-party suppliers and distributors affects those stakeholders.

Next Steps

• The company intends to use the proceeds from this offering for working capital, market penetration and development, operating expenses and transaction expenses.
• The company plans to expand its product offerings, enter new markets within ASEAN and Europe, and invest in new technologies to strengthen brand loyalty and develop its business.

Key Dates

Keywords

IPO, initial public offering, ordinary shares, healthcare, beauty products, EMPRO, EMPG, Nasdaq, Malaysia, cosmetics, skincare